Seattle Tuberculosis Research Advancement Center
Seattle Tuberculosis Research Advancement Center
批准号:
10595064
负责人:
Rhea N Coler
金额:
$104.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-21 至 2027-02-28
关键词:
AwardBasic ScienceBiometryChargeChildClinicalClinical ResearchClinical SciencesCollaborationsCommunitiesComputational BiologyConsultationsCountyData ScienceData Science CoreDevelopmentDirect CostsEducationEnsureEnvironmentEpidemicEthnic OriginEventFacultyFosteringFoundationsFred Hutchinson Cancer Research CenterFundingFutureGenderGrantHeartImmune responseImmunologyInstitutionInterdisciplinary StudyInternationalKenyaKnowledgeLeadLeadershipMedical ResearchMentorshipMethodologyMethodsMicrobiologyModelingMycobacterium tuberculosisPublic HealthResearchResearch InstituteResearch MethodologyResearch PersonnelScienceScientistSecureServicesStrategic PlanningSystems BiologyTrainingTranslational ResearchTranslationsTuberculosisUnited States National Institutes of HealthUniversitiesVisionWashingtoncareer developmentclinical databaseclinical epidemiologycohortcommunity buildingdesignimplementation scienceinterestmultidisciplinarynext generationprogramsrecruitskills
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (OVERALL)
The Vision of the Seattle Tuberculosis (TB) Research Advancement Center (SEA-TRAC) is to facilitate
a decrease in the global burden of TB through training and multi-disciplinary research. SEA-TRAC will
accomplish this by catalyzing new avenues of research and training a cadre of new investigators that will make
a meaningful impact on the global epidemic. SEA-TRAC will operate from three world class institutions in Seattle:
The University of Washington (UW), Seattle Children’s Research Institute, and Fred Hutchinson Cancer
Research Center. We will leverage close partnerships with local non-academic entities, such as the Institute for
Systems Biology, Public Health Seattle King County, and PATH as well as international partners, such as the
Kenya Medical Research Institute. The Administrative Core will lead SEA-TRAC and assume responsibility for
strategic planning and operational management as well as promoting an environment to foster dialogue that will
lead to new collaborations and funding applications. The heart of SEA-TRAC will be the Development Core,
which will oversee several new educational, training, and grant programs designed to foster career development
of junior or senior investigators that are new to TB research. The Clinical and Translational Science Core will
lead training and consulting in clinical research methodology and foster collaborative research with our
international partners. The Basic Science Core will provide training for scientists new to working in the Biosafety
Level 3 (BSL3) environment and lead training and consulting in advanced microbiology and immunology
methods. Finally, the Data Sciences Core will leverage our local strengths in Biostatistics, Computational
Biology, and Modeling to host community building events, such as TB ‘hackweeks,’ provide training to scientists
that are new to data science, and offer consulting services for advanced research questions. Our Leadership
Team is composed of faculty with a demonstrated commitment to training and mentorship that represent the
diversity of scientific interests, tenure stage, gender, and ethnicity of our research community. We have secured
institutional commitments totaling $861,420 or 29% of total direct costs that will allow us to support a diverse
suite of programs immediately upon funding. SEA-TRAC will build on the strong foundation that has been
established over the last five years by the UW Tuberculosis Research & Training Center (TRTC) to nucleate,
strengthen, and expand the impact of our research. By the end of the funding period, we expect that SEA-TRAC
will have achieved several quantifiable objectives and established itself as a flagship TRAC program, leading
new initiatives through interactions with other TRACs and the NIH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Seattle Tuberculosis Research Advancement Center
-
批准号:10425945
-
项目类别:
-
资助金额:$111.85万
-
财政年份:2022
-
负责人:Rhea N Coler
-
依托单位:
Advancing mycobacteriophage aerosol for prevention of pulmonary infections
-
批准号:10471170
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2021
-
负责人:Rhea N Coler
-
依托单位:
Identification of ID93+GLA-SE biomarkers for prevention of recurrent TB
-
批准号:9112761
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2016
-
负责人:Rhea N Coler
-
依托单位:
Identification of ID93+GLA-SE biomarkers for prevention of recurrent TB
-
批准号:9236150
-
项目类别:
-
资助金额:$13.4万
-
财政年份:2016
-
负责人:Rhea N Coler
-
依托单位:
Immuno-Chemotherapy to Shorten TB Treatment
-
批准号:8647793
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:Rhea N Coler
-
依托单位:
Immuno-Chemotherapy to Shorten TB Treatment
-
批准号:8883368
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:Rhea N Coler
-
依托单位:
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
-
批准号:7617909
-
项目类别:
-
资助金额:$149.16万
-
财政年份:2008
-
负责人:Rhea N Coler
-
依托单位:
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
-
批准号:7454641
-
项目类别:
-
资助金额:$97.93万
-
财政年份:2008
-
负责人:Rhea N Coler
-
依托单位:
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
-
批准号:8073661
-
项目类别:
-
资助金额:$171.7万
-
财政年份:2008
-
负责人:Rhea N Coler
-
依托单位:
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
-
批准号:7809517
-
项目类别:
-
资助金额:$201.78万
-
财政年份:2008
-
负责人:Rhea N Coler
-
依托单位:
Adjuvant Development Program
-
批准号:7868498
-
项目类别:
-
资助金额:$221.95万
-
财政年份:2008
-
负责人:Rhea N Coler
-
依托单位:
Characterization of a vaccine against Chlamydia trachomatis
-
批准号:7257687
-
项目类别:
-
资助金额:$25.19万
-
财政年份:2007
-
负责人:Rhea N Coler
-
依托单位:
Characterization of a vaccine against Chlamydia trachomatis
-
批准号:7499639
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2007
-
负责人:Rhea N Coler
-
依托单位:
海外基金